Ferrous bisglycinate vs ferrous sulfate — which iron, when, and why
Ferrous sulfate is the inexpensive, decades-old standard for treating iron-deficiency anaemia: ~20% elemental iron by weight, well-absorbed in an acidic gut, and consistently effective at raising hemoglobin. Its main flaw is GI side effects — constipation, nausea, dark stools, metallic taste — which cause many people to stop taking it before they're fully replete. Ferrous bisglycinate ("chelated" or "gentle" iron) is a glycine-chelated form designed to be better tolerated. Marketing implies it's the dramatically superior choice; the actual comparative trial data shows the difference is real but smaller than the price gap suggests.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Lowest-cost effective iron replacement | Ferrous sulfate | Generic 325 mg (65 mg elemental) tablets are the cheapest reliable iron source; raises hemoglobin effectively in iron-deficiency anaemia. |
| Better-tolerated iron when sulfate causes GI distress | Ferrous bisglycinate | Several head-to-head trials show fewer GI side effects with bisglycinate at matched elemental iron doses. |
| Iron repletion in pregnancy | Either; bisglycinate has tolerability edge | 2019 Fischer head-to-head in pregnant women showed similar hemoglobin response with fewer side effects on bisglycinate. |
| Fastest hemoglobin recovery in severe anaemia | IV iron — not either oral form | Severe symptomatic anaemia, malabsorption, or intolerance to oral iron warrants IV iron (iron sucrose, ferric carboxymaltose) under medical supervision. |
| Alternate-day dosing (modern protocol) | Either | The Stoffel 2017 finding — that alternate-day dosing produces better fractional absorption than daily dosing — applies to both forms via the hepcidin cycle. |
| Cost per day at typical 30 mg elemental dose | Ferrous sulfate | $0.05–0.15/day vs $0.30–0.80/day for bisglycinate; bigger gap in clinical-grade products. |
How they compare on the things that matter
Absorption — closer than the marketing implies
Both forms deliver bioavailable elemental iron to the duodenum. Ferrous sulfate releases ferrous ion (Fe²⁺) in the acidic stomach environment for transport by DMT1 in the duodenal enterocyte. Ferrous bisglycinate is absorbed partly as an intact chelate via a slightly different pathway, which is the theoretical basis for its better tolerability. Head-to-head absorption studies show modest or no superiority for bisglycinate when matched on elemental iron content; some studies favour bisglycinate marginally, others find no difference. The clinical bottom line: at matched elemental iron doses, hemoglobin response is similar.
GI tolerability — the actual difference
This is where bisglycinate genuinely earns its premium. Across several head-to-head trials including the Fischer 2019 randomised study in pregnancy, the Saha 2007 study in non-pregnant adults, and others, bisglycinate consistently produces fewer GI side effects than sulfate at matched elemental iron doses — particularly nausea, constipation, and abdominal discomfort. The effect is real but not dramatic; some users will still experience GI side effects on bisglycinate. For users who have failed ferrous sulfate due to GI intolerance, bisglycinate is the most evidence-based switch before going to IV iron.
The alternate-day dosing revolution
The single most important practical iron development of the past decade is the Stoffel 2017 finding that daily oral iron dosing triggers hepcidin elevation that reduces fractional absorption of subsequent doses for 24–48 hours. Alternate-day dosing (or even every-third-day dosing) produces higher fractional absorption per dose and similar or better total iron absorption with fewer side effects. This applies to both ferrous sulfate and ferrous bisglycinate. Modern best practice in iron-deficient adults: 60–120 mg elemental iron every other day on an empty stomach with vitamin C, rather than divided daily doses.
Dose and form
For ferrous sulfate: 325 mg tablets contain ~65 mg elemental iron. Standard adult iron-deficiency treatment is 60–120 mg elemental iron every other day (one tablet on alternate days). On a daily dosing regimen, 1–3 tablets daily, though alternate-day dosing is now preferred. Take on an empty stomach (1 hour before or 2 hours after meals) with 200 mg vitamin C to optimise absorption. Liquid preparations available for users who cannot swallow tablets.
For ferrous bisglycinate: marketed at 18–28 mg elemental iron per capsule in most brands. Same alternate-day, with vitamin C, on an empty stomach approach. The lower per-capsule elemental dose makes hitting a 60 mg target require multiple capsules; check the elemental iron content on the label rather than the chelate weight.
What to take alongside, and what to avoid
Vitamin C (200 mg or one orange) enhances non-heme iron absorption meaningfully — this matters for both forms. Avoid taking iron with calcium, dairy, coffee, tea, or eggs within 1 hour — all inhibit iron absorption substantially. Proton-pump inhibitors and H2 blockers reduce gastric acid and modestly reduce iron absorption; not a contraindication but a reason to ensure dose adequacy. Iron and levothyroxine should be separated by at least 4 hours.
Monitoring
Iron-deficiency anaemia treatment should be tracked with hemoglobin and ferritin. Hemoglobin typically begins to rise within 2 weeks and recovers over 8–12 weeks. Ferritin recovery (filling the iron stores) takes longer — often 3–6 months — and is the true endpoint of replacement therapy. Stopping iron when hemoglobin normalises without ferritin recovery commonly produces relapse. Target ferritin in symptomatic iron-deficient adults: ≥50–100 ng/mL depending on indication.
Safety
Iron overload is the central safety concern. Untreated hereditary hemochromatosis predisposes to organ damage from chronic iron loading; iron supplementation should not be casual in adult men or post-menopausal women without documented deficiency. Acute iron overdose is a leading cause of childhood supplement poisoning — keep iron supplements in child-resistant containers and out of reach.
Constipation, dark stools, and metallic taste are common on both forms (less common on bisglycinate). Iron stains teeth in liquid form (use a straw). Concurrent levodopa, levothyroxine, tetracyclines, fluoroquinolones, bisphosphonates: separate dosing by 4+ hours.
Who should skip each
Neither oral form is appropriate as primary therapy in adults with documented hereditary hemochromatosis without specialist supervision — these patients require iron removal (phlebotomy), not supplementation. Both should be paused during active infection (theoretical concern about iron and pathogen growth) — discuss with prescriber.
Children should not be given adult iron preparations without medical supervision; pediatric iron poisoning is a serious clinical entity. Pregnancy supplementation should be coordinated with obstetric care and standard prenatal iron content.
What we'd actually buy
For most adults with diagnosed iron-deficiency anaemia: generic ferrous sulfate 325 mg tablets, one every other day on an empty stomach with vitamin C, for 3–6 months until ferritin replete. Cheapest, most reliable, supported by the largest evidence base.
For users who have failed ferrous sulfate due to GI side effects (after trying alternate-day dosing): ferrous bisglycinate at matched elemental iron dose, every other day, same way.
For severe symptomatic iron-deficiency anaemia, malabsorption, inflammatory bowel disease, or repeated oral iron failure: discuss IV iron (iron sucrose or ferric carboxymaltose) with the prescribing clinician — much faster recovery than any oral form.
Sources
- Stoffel NU, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women. Lancet Haematol. 2017;4(11):e524–e533. PMID: 29032957
- Fischer JA, et al. The effects of oral ferrous bisglycinate and ferrous sulfate on iron absorption and oxidative stress in pregnant women with anemia. Eur J Nutr. 2023;62(3):1141–1150. PMID: 36474019
- Saha L, et al. Comparative study of ferrous bisglycinate versus ferrous sulfate in iron-deficiency anemia. Med J Indones. 2007;16(1). (Methodology summary reviewed.)
- Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–1843. PMID: 25946282
- Stoffel NU, et al. Oral iron supplementation in iron-deficient women: how much and how often? Mol Aspects Med. 2020;75:100865. PMID: 32650988
- Tolkien Z, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383. PMID: 25700159